{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:24Z","timestamp":1786121364903,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent atrial fibrillation (AF) and heart failure (HF) may promote right-heart remodeling and functional tricuspid regurgitation (FTR). Evidence regarding right-heart changes after first AF ablation in patients with persistent AF, HF, and FTR remains limited. This study assessed 12-month right-heart reverse remodeling and its associations with HF symptoms and exploratory clinical events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center cohort included 210 patients with persistent AF, HF with reduced, mildly reduced, or preserved ejection fraction, and at least mild FTR undergoing first catheter ablation. Transthoracic echocardiography (TTE) was performed at baseline and 12 months. Significant right-heart reverse remodeling was defined as a \u226510% reduction in right atrial volume index (RAVI) plus a \u226510% reduction in right ventricular (RV) basal diameter or tricuspid annular diameter, without worsening tricuspid regurgitation (TR) or RV function. Logistic regression, rhythm\/loading and threshold sensitivity analyses, and 12-month landmark Cox models were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 12 months, RAVI changed by \u221219.3% [interquartile range (IQR), \u221230.5% to \u22126.8%]; 93 patients (44.3%) achieved remodeling, 57.1% had TR improvement, and 61.0% had HF symptom improvement. Sinus rhythm during echocardiography increased from 16.7% to 78.6%, while heart failure guideline-directed medical therapy (HF-GDMT) and sodium-glucose cotransporter 2 (SGLT2)-inhibitor use increased. Same-rhythm and rhythm\/loading-adjusted analyses showed directionally consistent but attenuated improvements in right-heart dimensions, pulmonary artery systolic pressure, and TR grade. Long-standing persistent AF, higher baseline RAVI, higher pulmonary artery systolic pressure, and arrhythmia recurrence within 12 months were associated with lower odds of remodeling, whereas higher estimated glomerular filtration rate (eGFR) and HF-GDMT were associated with higher odds. After the 12-month landmark, arrhythmia recurrence and HF rehospitalization were less frequent with remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-arm retrospective cohort, right-heart reverse remodeling observed after first AF ablation was associated with TR improvement, HF symptom improvement, and lower exploratory post-landmark event rates. The single-arm design, rhythm\/loading changes, HF-GDMT intensification, and short post-landmark follow-up support associative and hypothesis-generating interpretation; causal attribution requires prospective controlled studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1899959","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:21:40Z","timestamp":1786076500000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Right-heart reverse remodeling and heart failure symptom outcomes after catheter ablation in patients with persistent atrial fibrillation, heart failure, and functional tricuspid regurgitation"],"prefix":"10.3389","volume":"13","author":[{"given":"Ya","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Arrhythmia, Cangzhou Central Hospital","place":["Cangzhou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Arrhythmia, Cangzhou Central Hospital","place":["Cangzhou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Arrhythmia, Cangzhou Central Hospital","place":["Cangzhou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Arrhythmia, Cangzhou Central Hospital","place":["Cangzhou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Arrhythmia, Cangzhou Central Hospital","place":["Cangzhou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11897-024-00691-9","article-title":"Atrial fibrillation in heart failure: novel insights, challenges, and treatment opportunities","volume":"22","author":"Bidaoui","year":"2024","journal-title":"Curr Heart Fail Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1349584","DOI":"10.3389\/fcvm.2024.1349584","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: clinical management in the context of recent therapeutic advances in heart failure and electrophysiology","volume":"11","author":"Yang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.31083\/j.rcm2512435","article-title":"Atrial functional tricuspid regurgitation: a comprehensive review of pathophysiology, diagnosis, and management strategies","volume":"25","author":"Mohyeldin","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurheartj\/ehae088","article-title":"Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment","volume":"45","author":"Muraru","year":"2024","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e022713","DOI":"10.1161\/JAHA.121.022713","article-title":"Effect of tricuspid regurgitation on the reported quality of life and subsequent outcomes in patients with atrial fibrillation","volume":"11","author":"Fujisawa","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1350536","DOI":"10.3389\/fcvm.2024.1350536","article-title":"Contemporary evaluation and treatment of tricuspid regurgitation","volume":"11","author":"Minciunescu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"euad363","DOI":"10.1093\/europace\/euad363","article-title":"Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction","volume":"26","author":"Xie","year":"2024","journal-title":"Europace"},{"key":"B8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamacardio.2024.0675","article-title":"Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis","volume":"9","author":"Oraii","year":"2024","journal-title":"JAMA Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.hroo.2025.05.015","article-title":"Catheter ablation for atrial fibrillation in patients with tricuspid regurgitation","volume":"6","author":"Isenegger","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70319","DOI":"10.1111\/echo.70319","article-title":"Evaluation of the remodeling of the tricuspid annulus and right heart in persistent atrial fibrillation patients with or without radiofrequency ablation via three-dimensional echocardiography","volume":"42","author":"Tian","year":"2025","journal-title":"Echocardiography"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 Acc\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 Aha\/ACC\/HFSA guideline for the management of heart failure","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1011931","DOI":"10.3389\/fcvm.2022.1011931","article-title":"Reference ranges of tricuspid annulus geometry in healthy adults using a dedicated three-dimensional echocardiography software package","volume":"9","author":"Muraru","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4070\/kcj.2023.0312","article-title":"The effects of radiofrequency catheter ablation for atrial fibrillation on right ventricular function","volume":"54","author":"Kim","year":"2024","journal-title":"Korean Circ J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler","year":"2023","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"B18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s13019-024-02891-9","article-title":"Sinus rhythm restoration reverses tricuspid regurgitation in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"19","author":"Zhan","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1600238","DOI":"10.3389\/fcvm.2025.1600238","article-title":"Long-term outcome of catheter ablation in patients with persistent atrial fibrillation and functional tricuspid regurgitation","volume":"12","author":"Liu","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/ehf2.15197","article-title":"Severity of tricuspid regurgitation predicts risk of recurrence of atrial fibrillation after pulmonary vein isolation","volume":"12","author":"Wintrich","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101623","DOI":"10.1016\/j.jacadv.2025.101623","article-title":"Atrial functional tricuspid regurgitation: contemporary characteristics, outcomes, and novel risk score","volume":"4","author":"Fava","year":"2025","journal-title":"JACC Adv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1022755","DOI":"10.3389\/fcvm.2022.1022755","article-title":"The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype","volume":"9","author":"Gavazzoni","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ejhf.3678","article-title":"Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry","volume":"27","author":"Lupi","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1428964","DOI":"10.3389\/fcvm.2025.1428964","article-title":"Predictors of significant tricuspid regurgitation in atrial fibrillation: a meta-analysis","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1575750","DOI":"10.3389\/fcvm.2025.1575750","article-title":"Left atrial pressure and significant tricuspid regurgitation in persistent atrial fibrillation","volume":"12","author":"Lin","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.3390\/jcm14176227","article-title":"Outcomes of atrial fibrillation ablation in patients with chronic kidney disease","volume":"14","author":"Abbo","year":"2025","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamacardio.2024.3023","article-title":"Global impact of optimal implementation of guideline-directed medical therapy in heart failure","volume":"9","author":"Tang","year":"2024","journal-title":"JAMA Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2428032","DOI":"10.1001\/jamanetworkopen.2024.28032","article-title":"Clinical outcomes of mitral valve surgery in atrial functional mitral regurgitation in the REVEAL-AFMR registry","volume":"7","author":"Kagiyama","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1573403X348844","DOI":"10.2174\/011573403X348844241129111639","article-title":"Atrial fibrillation ablation in heart failure and preserved ejection fraction: an observational study of risk factors for heart failure hospitalization","volume":"21","author":"Qi","year":"2025","journal-title":"Curr Cardiol Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/ehf2.14448","article-title":"Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study","volume":"10","author":"Gonz\u00e1lez-Ferrero","year":"2023","journal-title":"ESC Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"103311","DOI":"10.1016\/j.jaccas.2025.103311","article-title":"Rhythm control of atrial fibrillation positively affects tricuspid regurgitation","volume":"30","author":"Lebehn","year":"2025","journal-title":"JACC Case Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.31083\/j.rcm2509330","article-title":"Tricuspid regurgitation complicating heart failure: a novel clinical entity","volume":"25","author":"Xi","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3000605241240583","DOI":"10.1177\/03000605241240583","article-title":"Assessing emerging causes of mitral regurgitation: atrial functional mitral regurgitation","volume":"52","author":"Nappi","year":"2024","journal-title":"J Int Med Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4070\/kcj.2025.0041","article-title":"Influence of rhythm control on functional mitral and tricuspid regurgitation severity and clinical outcome in patients with atrial fibrillation","volume":"55","author":"Park","year":"2025","journal-title":"Korean Circ J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10557-023-07489-2","article-title":"Effects of rhythm control for atrial fibrillation on cardiac remodeling and valvular regurgitation in patients with heart failure","volume":"39","author":"Si","year":"2025","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1899959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:21:41Z","timestamp":1786076501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1899959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2026.1899959"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1899959","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1899959"}}